| 1 | random | 8,926 |
| 2 | non-random | 74 |
| 3 | multilocus | 68 |
| 4 | nonrandom | 48 |
| 5 | respondent-driven | 28 |
| 6 | do-not-resuscitate | 23 |
| 7 | multi-locus | 20 |
| 8 | study-group | 17 |
| 9 | alphabetic | 15 |
| 10 | multiplier | 14 |
| 11 | calcium-enriched | 11 |
| 12 | pseudo-random | 9 |
| 13 | pseudorandom | 9 |
| 14 | alphabetical | 8 |
| 15 | non-probabilistic | 8 |
| 16 | möbius | 7 |
| 17 | pseudo-first | 7 |
| 18 | 'side | 6 |
| 19 | non-inverted | 6 |
| 20 | pseudo-second | 6 |
| 21 | figure-eight | 5 |
| 22 | first-served | 5 |
| 23 | mandala | 5 |
| 24 | propofol-lidocaine | 5 |
| 25 | cluster-randomization | 4 |
| 26 | genome-level | 4 |
| 27 | nikon | 4 |
| 28 | well-coordinated | 4 |
| 29 | 25-ml | 3 |
| 30 | bidding | 3 |
| 31 | cover-specific | 3 |
| 32 | discriminative-stimulus | 3 |
| 33 | field-amplified | 3 |
| 34 | four-digit | 3 |
| 35 | fourth-fifth | 3 |
| 36 | hitchhiking | 3 |
| 37 | inter-simple | 3 |
| 38 | meld-based | 3 |
| 39 | pan-fungal | 3 |
| 40 | sleep-stage | 3 |
| 41 | tki-everolimus-tki | 3 |
| 42 | 'shifted | 2 |
| 43 | 5,518-patient | 2 |
| 44 | caudovirales | 2 |
| 45 | chip-specific | 2 |
| 46 | colonoscopy-egd | 2 |
| 47 | design-adaptive | 2 |
| 48 | design-random | 2 |
| 49 | double-helical | 2 |
| 50 | exercise-albuterol | 2 |
| 51 | fasta | 2 |
| 52 | fentanyl-bupivacaine | 2 |
| 53 | filtered-seawater | 2 |
| 54 | go-schiff | 2 |
| 55 | gooseneck | 2 |
| 56 | hyperplasia-carcinoma | 2 |
| 57 | mucorales | 2 |
| 58 | multiple-locus | 2 |
| 59 | nine-amino-acid | 2 |
| 60 | nomogram-based | 2 |
| 61 | nontriggered | 2 |
| 62 | peak-first | 2 |
| 63 | population-proportionate | 2 |
| 64 | purple-colored | 2 |
| 65 | r-u5-5'leader | 2 |
| 66 | random-allocation | 2 |
| 67 | reasoned/intention | 2 |
| 68 | sa-mediated | 2 |
| 69 | saturation-recovery | 2 |
| 70 | stellated | 2 |
| 71 | tenax-ta™ | 2 |
| 72 | tri-capped | 2 |
| 73 | trz-pla | 2 |
| 74 | water/acetonitrile | 2 |
| 75 | yanhouling | 2 |
| 76 | 'country | 1 |
| 77 | 'prebiotic | 1 |
| 78 | 1.4th | 1 |
| 79 | 1.5st | 1 |
| 80 | 150-bp | 1 |
| 81 | 17-aa | 1 |
| 82 | 17-amino-acid | 1 |
| 83 | 1:1:1.5 | 1 |
| 84 | 2-sigma | 1 |
| 85 | 20q-amplified | 1 |
| 86 | 283-patient | 1 |
| 87 | 3:2:3 | 1 |
| 88 | 4-element | 1 |
| 89 | 4=a | 1 |
| 90 | 5-element | 1 |
| 91 | 661bp | 1 |
| 92 | 96:4 | 1 |
| 93 | acc-specific | 1 |
| 94 | acetone/n-hexane | 1 |
| 95 | aggravative | 1 |
| 96 | alleatory | 1 |
| 97 | analysis-identified | 1 |
| 98 | antiinflammatory/antioxidant | 1 |
| 99 | bcl-3·p50 | 1 |
| 100 | blind-to-treatment | 1 |
| 101 | bothriocephalidean | 1 |
| 102 | btf3-related | 1 |
| 103 | bulbar/spinal | 1 |
| 104 | bupivacaine-epinephrine | 1 |
| 105 | c-myc-driven | 1 |
| 106 | centrohelid | 1 |
| 107 | ch3cn-h2o | 1 |
| 108 | charge-sensitive | 1 |
| 109 | choreotrich | 1 |
| 110 | clinic/patient | 1 |
| 111 | computerized-generating | 1 |
| 112 | concealed-to-random | 1 |
| 113 | cover-to-cover | 1 |
| 114 | cross-balanced | 1 |
| 115 | cross-generational | 1 |
| 116 | cyanobacterial-specific | 1 |
| 117 | data/measurement | 1 |
| 118 | dative-only | 1 |
| 119 | deflazacort.adverse | 1 |
| 120 | deprotonation/oxidation | 1 |
| 121 | dioctophimatid | 1 |
| 122 | diphyllobothriid | 1 |
| 123 | elastase-lowering | 1 |
| 124 | est-single | 1 |
| 125 | extended-clinician.a | 1 |
| 126 | far-removed | 1 |
| 127 | field-isolated | 1 |
| 128 | filaroid | 1 |
| 129 | filter-aided | 1 |
| 130 | free-rider | 1 |
| 131 | furosemide-placebo | 1 |
| 132 | fuzhengliqi | 1 |
| 133 | galacto/fructooligosaccharide | 1 |
| 134 | gh-independent | 1 |
| 135 | ha/dbm | 1 |
| 136 | hcg.the | 1 |
| 137 | hepatic-pedicle | 1 |
| 138 | hgf-mediated | 1 |
| 139 | high-cell-density | 1 |
| 140 | high-low-pitch | 1 |
| 141 | hno3-hcl-hclo4-hf | 1 |
| 142 | hospitalet | 1 |
| 143 | hsp70-beta | 1 |
| 144 | hydroxynaphthoquinone | 1 |
| 145 | hypothermia-in | 1 |
| 146 | index-mediated | 1 |
| 147 | inter-varietal | 1 |
| 148 | isotonized | 1 |
| 149 | itsr | 1 |
| 150 | kidney/drug | 1 |
| 151 | lac-ga-cs | 1 |
| 152 | lengthening-shortening | 1 |
| 153 | li9 | 1 |
| 154 | lichrosep | 1 |
| 155 | lipari-szabo | 1 |
| 156 | low-nitrogen | 1 |
| 157 | maize-poultry | 1 |
| 158 | md/mba | 1 |
| 159 | mean*/standard | 1 |
| 160 | meaning/context | 1 |
| 161 | membrane-depolarizing | 1 |
| 162 | mepivacaine-bupivacaine | 1 |
| 163 | methane-xenon | 1 |
| 164 | min*g | 1 |
| 165 | minimal.although | 1 |
| 166 | molasses-supplemented | 1 |
| 167 | monoxen | 1 |
| 168 | multi-level-mixed | 1 |
| 169 | mycoplasma-infected | 1 |
| 170 | nanoliter | 1 |
| 171 | narcotic-sparing | 1 |
| 172 | negative/dysphoric | 1 |
| 173 | next-to-leading | 1 |
| 174 | night-both | 1 |
| 175 | nitrate-replete | 1 |
| 176 | nlx-loaded | 1 |
| 177 | nmg-1 | 1 |
| 178 | non-genuine | 1 |
| 179 | nonrecovering | 1 |
| 180 | observation-trial | 1 |
| 181 | odd/even | 1 |
| 182 | pap/watt | 1 |
| 183 | partners.the | 1 |
| 184 | patient/group | 1 |
| 185 | per-group | 1 |
| 186 | pestilential | 1 |
| 187 | pfge/multilocus | 1 |
| 188 | pgl3-cre | 1 |
| 189 | phakolytic | 1 |
| 190 | pisf/gcf | 1 |
| 191 | poisonings.exact | 1 |
| 192 | postrandom | 1 |
| 193 | ppar-gamma-mediated | 1 |
| 194 | pre-digested | 1 |
| 195 | predigested | 1 |
| 196 | previously.the | 1 |
| 197 | proactive-interference | 1 |
| 198 | proton-weighted | 1 |
| 199 | protozoan-free | 1 |
| 200 | quota-adjusted | 1 |
| 201 | random-exposure | 1 |
| 202 | randomic | 1 |
| 203 | randomisation-allocation | 1 |
| 204 | rapidly-adhering | 1 |
| 205 | reported.in | 1 |
| 206 | revive-ii | 1 |
| 207 | rhodophytan | 1 |
| 208 | salivarian | 1 |
| 209 | salt/ice | 1 |
| 210 | scopolamine-block/placebo-block | 1 |
| 211 | screen-stratified | 1 |
| 212 | self-fabricated | 1 |
| 213 | self-modelling | 1 |
| 214 | semiconductor-type | 1 |
| 215 | sensor-off/on | 1 |
| 216 | sequentially-numbered | 1 |
| 217 | short-wave-sensitive | 1 |
| 218 | signal-to-3rd | 1 |
| 219 | single-taste-cell | 1 |
| 220 | sleep-producing | 1 |
| 221 | society.in | 1 |
| 222 | spb-specific | 1 |
| 223 | spin-parity | 1 |
| 224 | spliced-leader | 1 |
| 225 | st571 | 1 |
| 226 | stable-calcium | 1 |
| 227 | structurally-complex | 1 |
| 228 | study-arm | 1 |
| 229 | sub-random | 1 |
| 230 | surumi | 1 |
| 231 | syndinian | 1 |
| 232 | telomere-dependent | 1 |
| 233 | terpene-based | 1 |
| 234 | thiosulfate-reducing | 1 |
| 235 | three-host | 1 |
| 236 | thy-car | 1 |
| 237 | tki-everolimus | 1 |
| 238 | tools.a | 1 |
| 239 | transversion-enriched | 1 |
| 240 | trichomonad-like | 1 |
| 241 | triplet/higher | 1 |
| 242 | tyr-lys-asp-gly | 1 |
| 243 | vasoconstrictive/proliferative | 1 |
| 244 | vcl4/sbcl5 | 1 |
| 245 | vol-tas | 1 |
| 246 | wavenumber-linearization | 1 |
| 247 | waypoint-based | 1 |
| 248 | weight-inducing | 1 |
| 249 | whole-tumour-cell | 1 |
| 250 | γ-tocopherol-rich | 1 |
| 1 | 'country | 1 |
| 2 | 'prebiotic | 1 |
| 3 | 'shifted | 2 |
| 4 | 'side | 6 |
| 5 | 1.4th | 1 |
| 6 | 1.5st | 1 |
| 7 | 150-bp | 1 |
| 8 | 17-aa | 1 |
| 9 | 17-amino-acid | 1 |
| 10 | 1:1:1.5 | 1 |
| 11 | 2-sigma | 1 |
| 12 | 20q-amplified | 1 |
| 13 | 25-ml | 3 |
| 14 | 283-patient | 1 |
| 15 | 3:2:3 | 1 |
| 16 | 4-element | 1 |
| 17 | 4=a | 1 |
| 18 | 5,518-patient | 2 |
| 19 | 5-element | 1 |
| 20 | 661bp | 1 |
| 21 | 96:4 | 1 |
| 22 | acc-specific | 1 |
| 23 | acetone/n-hexane | 1 |
| 24 | aggravative | 1 |
| 25 | alleatory | 1 |
| 26 | alphabetic | 15 |
| 27 | alphabetical | 8 |
| 28 | analysis-identified | 1 |
| 29 | antiinflammatory/antioxidant | 1 |
| 30 | bcl-3·p50 | 1 |
| 31 | bidding | 3 |
| 32 | blind-to-treatment | 1 |
| 33 | bothriocephalidean | 1 |
| 34 | btf3-related | 1 |
| 35 | bulbar/spinal | 1 |
| 36 | bupivacaine-epinephrine | 1 |
| 37 | c-myc-driven | 1 |
| 38 | calcium-enriched | 11 |
| 39 | caudovirales | 2 |
| 40 | centrohelid | 1 |
| 41 | ch3cn-h2o | 1 |
| 42 | charge-sensitive | 1 |
| 43 | chip-specific | 2 |
| 44 | choreotrich | 1 |
| 45 | clinic/patient | 1 |
| 46 | cluster-randomization | 4 |
| 47 | colonoscopy-egd | 2 |
| 48 | computerized-generating | 1 |
| 49 | concealed-to-random | 1 |
| 50 | cover-specific | 3 |
| 51 | cover-to-cover | 1 |
| 52 | cross-balanced | 1 |
| 53 | cross-generational | 1 |
| 54 | cyanobacterial-specific | 1 |
| 55 | data/measurement | 1 |
| 56 | dative-only | 1 |
| 57 | deflazacort.adverse | 1 |
| 58 | deprotonation/oxidation | 1 |
| 59 | design-adaptive | 2 |
| 60 | design-random | 2 |
| 61 | dioctophimatid | 1 |
| 62 | diphyllobothriid | 1 |
| 63 | discriminative-stimulus | 3 |
| 64 | do-not-resuscitate | 23 |
| 65 | double-helical | 2 |
| 66 | elastase-lowering | 1 |
| 67 | est-single | 1 |
| 68 | exercise-albuterol | 2 |
| 69 | extended-clinician.a | 1 |
| 70 | far-removed | 1 |
| 71 | fasta | 2 |
| 72 | fentanyl-bupivacaine | 2 |
| 73 | field-amplified | 3 |
| 74 | field-isolated | 1 |
| 75 | figure-eight | 5 |
| 76 | filaroid | 1 |
| 77 | filter-aided | 1 |
| 78 | filtered-seawater | 2 |
| 79 | first-served | 5 |
| 80 | four-digit | 3 |
| 81 | fourth-fifth | 3 |
| 82 | free-rider | 1 |
| 83 | furosemide-placebo | 1 |
| 84 | fuzhengliqi | 1 |
| 85 | galacto/fructooligosaccharide | 1 |
| 86 | genome-level | 4 |
| 87 | gh-independent | 1 |
| 88 | go-schiff | 2 |
| 89 | gooseneck | 2 |
| 90 | ha/dbm | 1 |
| 91 | hcg.the | 1 |
| 92 | hepatic-pedicle | 1 |
| 93 | hgf-mediated | 1 |
| 94 | high-cell-density | 1 |
| 95 | high-low-pitch | 1 |
| 96 | hitchhiking | 3 |
| 97 | hno3-hcl-hclo4-hf | 1 |
| 98 | hospitalet | 1 |
| 99 | hsp70-beta | 1 |
| 100 | hydroxynaphthoquinone | 1 |
| 101 | hyperplasia-carcinoma | 2 |
| 102 | hypothermia-in | 1 |
| 103 | index-mediated | 1 |
| 104 | inter-simple | 3 |
| 105 | inter-varietal | 1 |
| 106 | isotonized | 1 |
| 107 | itsr | 1 |
| 108 | kidney/drug | 1 |
| 109 | lac-ga-cs | 1 |
| 110 | lengthening-shortening | 1 |
| 111 | li9 | 1 |
| 112 | lichrosep | 1 |
| 113 | lipari-szabo | 1 |
| 114 | low-nitrogen | 1 |
| 115 | maize-poultry | 1 |
| 116 | mandala | 5 |
| 117 | md/mba | 1 |
| 118 | mean*/standard | 1 |
| 119 | meaning/context | 1 |
| 120 | meld-based | 3 |
| 121 | membrane-depolarizing | 1 |
| 122 | mepivacaine-bupivacaine | 1 |
| 123 | methane-xenon | 1 |
| 124 | min*g | 1 |
| 125 | minimal.although | 1 |
| 126 | molasses-supplemented | 1 |
| 127 | monoxen | 1 |
| 128 | mucorales | 2 |
| 129 | multi-level-mixed | 1 |
| 130 | multi-locus | 20 |
| 131 | multilocus | 68 |
| 132 | multiple-locus | 2 |
| 133 | multiplier | 14 |
| 134 | mycoplasma-infected | 1 |
| 135 | möbius | 7 |
| 136 | nanoliter | 1 |
| 137 | narcotic-sparing | 1 |
| 138 | negative/dysphoric | 1 |
| 139 | next-to-leading | 1 |
| 140 | night-both | 1 |
| 141 | nikon | 4 |
| 142 | nine-amino-acid | 2 |
| 143 | nitrate-replete | 1 |
| 144 | nlx-loaded | 1 |
| 145 | nmg-1 | 1 |
| 146 | nomogram-based | 2 |
| 147 | non-genuine | 1 |
| 148 | non-inverted | 6 |
| 149 | non-probabilistic | 8 |
| 150 | non-random | 74 |
| 151 | nonrandom | 48 |
| 152 | nonrecovering | 1 |
| 153 | nontriggered | 2 |
| 154 | observation-trial | 1 |
| 155 | odd/even | 1 |
| 156 | pan-fungal | 3 |
| 157 | pap/watt | 1 |
| 158 | partners.the | 1 |
| 159 | patient/group | 1 |
| 160 | peak-first | 2 |
| 161 | per-group | 1 |
| 162 | pestilential | 1 |
| 163 | pfge/multilocus | 1 |
| 164 | pgl3-cre | 1 |
| 165 | phakolytic | 1 |
| 166 | pisf/gcf | 1 |
| 167 | poisonings.exact | 1 |
| 168 | population-proportionate | 2 |
| 169 | postrandom | 1 |
| 170 | ppar-gamma-mediated | 1 |
| 171 | pre-digested | 1 |
| 172 | predigested | 1 |
| 173 | previously.the | 1 |
| 174 | proactive-interference | 1 |
| 175 | propofol-lidocaine | 5 |
| 176 | proton-weighted | 1 |
| 177 | protozoan-free | 1 |
| 178 | pseudo-first | 7 |
| 179 | pseudo-random | 9 |
| 180 | pseudo-second | 6 |
| 181 | pseudorandom | 9 |
| 182 | purple-colored | 2 |
| 183 | quota-adjusted | 1 |
| 184 | r-u5-5'leader | 2 |
| 185 | random | 8,926 |
| 186 | random-allocation | 2 |
| 187 | random-exposure | 1 |
| 188 | randomic | 1 |
| 189 | randomisation-allocation | 1 |
| 190 | rapidly-adhering | 1 |
| 191 | reasoned/intention | 2 |
| 192 | reported.in | 1 |
| 193 | respondent-driven | 28 |
| 194 | revive-ii | 1 |
| 195 | rhodophytan | 1 |
| 196 | sa-mediated | 2 |
| 197 | salivarian | 1 |
| 198 | salt/ice | 1 |
| 199 | saturation-recovery | 2 |
| 200 | scopolamine-block/placebo-block | 1 |
| 201 | screen-stratified | 1 |
| 202 | self-fabricated | 1 |
| 203 | self-modelling | 1 |
| 204 | semiconductor-type | 1 |
| 205 | sensor-off/on | 1 |
| 206 | sequentially-numbered | 1 |
| 207 | short-wave-sensitive | 1 |
| 208 | signal-to-3rd | 1 |
| 209 | single-taste-cell | 1 |
| 210 | sleep-producing | 1 |
| 211 | sleep-stage | 3 |
| 212 | society.in | 1 |
| 213 | spb-specific | 1 |
| 214 | spin-parity | 1 |
| 215 | spliced-leader | 1 |
| 216 | st571 | 1 |
| 217 | stable-calcium | 1 |
| 218 | stellated | 2 |
| 219 | structurally-complex | 1 |
| 220 | study-arm | 1 |
| 221 | study-group | 17 |
| 222 | sub-random | 1 |
| 223 | surumi | 1 |
| 224 | syndinian | 1 |
| 225 | telomere-dependent | 1 |
| 226 | tenax-ta™ | 2 |
| 227 | terpene-based | 1 |
| 228 | thiosulfate-reducing | 1 |
| 229 | three-host | 1 |
| 230 | thy-car | 1 |
| 231 | tki-everolimus | 1 |
| 232 | tki-everolimus-tki | 3 |
| 233 | tools.a | 1 |
| 234 | transversion-enriched | 1 |
| 235 | tri-capped | 2 |
| 236 | trichomonad-like | 1 |
| 237 | triplet/higher | 1 |
| 238 | trz-pla | 2 |
| 239 | tyr-lys-asp-gly | 1 |
| 240 | vasoconstrictive/proliferative | 1 |
| 241 | vcl4/sbcl5 | 1 |
| 242 | vol-tas | 1 |
| 243 | water/acetonitrile | 2 |
| 244 | wavenumber-linearization | 1 |
| 245 | waypoint-based | 1 |
| 246 | weight-inducing | 1 |
| 247 | well-coordinated | 4 |
| 248 | whole-tumour-cell | 1 |
| 249 | yanhouling | 2 |
| 250 | γ-tocopherol-rich | 1 |
| 1 | bcl-3·p50 | 1 |
| 2 | nmg-1 | 1 |
| 3 | st571 | 1 |
| 4 | 3:2:3 | 1 |
| 5 | 96:4 | 1 |
| 6 | 1:1:1.5 | 1 |
| 7 | vcl4/sbcl5 | 1 |
| 8 | li9 | 1 |
| 9 | extended-clinician.a | 1 |
| 10 | tools.a | 1 |
| 11 | 4=a | 1 |
| 12 | 17-aa | 1 |
| 13 | md/mba | 1 |
| 14 | mandala | 5 |
| 15 | trz-pla | 2 |
| 16 | 2-sigma | 1 |
| 17 | hyperplasia-carcinoma | 2 |
| 18 | hsp70-beta | 1 |
| 19 | fasta | 2 |
| 20 | spb-specific | 1 |
| 21 | acc-specific | 1 |
| 22 | cyanobacterial-specific | 1 |
| 23 | chip-specific | 2 |
| 24 | cover-specific | 3 |
| 25 | randomic | 1 |
| 26 | negative/dysphoric | 1 |
| 27 | alphabetic | 15 |
| 28 | 'prebiotic | 1 |
| 29 | non-probabilistic | 8 |
| 30 | phakolytic | 1 |
| 31 | cross-balanced | 1 |
| 32 | nlx-loaded | 1 |
| 33 | filter-aided | 1 |
| 34 | calcium-enriched | 11 |
| 35 | transversion-enriched | 1 |
| 36 | field-amplified | 3 |
| 37 | 20q-amplified | 1 |
| 38 | screen-stratified | 1 |
| 39 | analysis-identified | 1 |
| 40 | tri-capped | 2 |
| 41 | sequentially-numbered | 1 |
| 42 | nontriggered | 2 |
| 43 | purple-colored | 2 |
| 44 | meld-based | 3 |
| 45 | terpene-based | 1 |
| 46 | nomogram-based | 2 |
| 47 | waypoint-based | 1 |
| 48 | self-fabricated | 1 |
| 49 | ppar-gamma-mediated | 1 |
| 50 | sa-mediated | 2 |
| 51 | hgf-mediated | 1 |
| 52 | index-mediated | 1 |
| 53 | btf3-related | 1 |
| 54 | stellated | 2 |
| 55 | field-isolated | 1 |
| 56 | well-coordinated | 4 |
| 57 | mycoplasma-infected | 1 |
| 58 | 'shifted | 2 |
| 59 | proton-weighted | 1 |
| 60 | molasses-supplemented | 1 |
| 61 | non-inverted | 6 |
| 62 | pre-digested | 1 |
| 63 | predigested | 1 |
| 64 | quota-adjusted | 1 |
| 65 | far-removed | 1 |
| 66 | first-served | 5 |
| 67 | multi-level-mixed | 1 |
| 68 | isotonized | 1 |
| 69 | colonoscopy-egd | 2 |
| 70 | 17-amino-acid | 1 |
| 71 | nine-amino-acid | 2 |
| 72 | diphyllobothriid | 1 |
| 73 | centrohelid | 1 |
| 74 | filaroid | 1 |
| 75 | dioctophimatid | 1 |
| 76 | pseudo-second | 6 |
| 77 | signal-to-3rd | 1 |
| 78 | mean*/standard | 1 |
| 79 | salt/ice | 1 |
| 80 | proactive-interference | 1 |
| 81 | galacto/fructooligosaccharide | 1 |
| 82 | 'side | 6 |
| 83 | protozoan-free | 1 |
| 84 | sleep-stage | 3 |
| 85 | hcg.the | 1 |
| 86 | partners.the | 1 |
| 87 | previously.the | 1 |
| 88 | trichomonad-like | 1 |
| 89 | hepatic-pedicle | 1 |
| 90 | est-single | 1 |
| 91 | water/acetonitrile | 2 |
| 92 | inter-simple | 3 |
| 93 | acetone/n-hexane | 1 |
| 94 | mepivacaine-bupivacaine | 1 |
| 95 | fentanyl-bupivacaine | 2 |
| 96 | propofol-lidocaine | 5 |
| 97 | bupivacaine-epinephrine | 1 |
| 98 | non-genuine | 1 |
| 99 | hydroxynaphthoquinone | 1 |
| 100 | semiconductor-type | 1 |
| 101 | pgl3-cre | 1 |
| 102 | random-exposure | 1 |
| 103 | deflazacort.adverse | 1 |
| 104 | population-proportionate | 2 |
| 105 | do-not-resuscitate | 23 |
| 106 | nitrate-replete | 1 |
| 107 | vasoconstrictive/proliferative | 1 |
| 108 | aggravative | 1 |
| 109 | charge-sensitive | 1 |
| 110 | short-wave-sensitive | 1 |
| 111 | design-adaptive | 2 |
| 112 | pisf/gcf | 1 |
| 113 | go-schiff | 2 |
| 114 | hno3-hcl-hclo4-hf | 1 |
| 115 | min*g | 1 |
| 116 | thiosulfate-reducing | 1 |
| 117 | weight-inducing | 1 |
| 118 | sleep-producing | 1 |
| 119 | next-to-leading | 1 |
| 120 | bidding | 3 |
| 121 | hitchhiking | 3 |
| 122 | self-modelling | 1 |
| 123 | yanhouling | 2 |
| 124 | lengthening-shortening | 1 |
| 125 | narcotic-sparing | 1 |
| 126 | rapidly-adhering | 1 |
| 127 | nonrecovering | 1 |
| 128 | elastase-lowering | 1 |
| 129 | computerized-generating | 1 |
| 130 | membrane-depolarizing | 1 |
| 131 | kidney/drug | 1 |
| 132 | γ-tocopherol-rich | 1 |
| 133 | choreotrich | 1 |
| 134 | high-low-pitch | 1 |
| 135 | minimal.although | 1 |
| 136 | 1.4th | 1 |
| 137 | fourth-fifth | 3 |
| 138 | night-both | 1 |
| 139 | revive-ii | 1 |
| 140 | tki-everolimus-tki | 3 |
| 141 | surumi | 1 |
| 142 | fuzhengliqi | 1 |
| 143 | gooseneck | 2 |
| 144 | scopolamine-block/placebo-block | 1 |
| 145 | double-helical | 2 |
| 146 | alphabetical | 8 |
| 147 | pan-fungal | 3 |
| 148 | observation-trial | 1 |
| 149 | pestilential | 1 |
| 150 | bulbar/spinal | 1 |
| 151 | cross-generational | 1 |
| 152 | inter-varietal | 1 |
| 153 | genome-level | 4 |
| 154 | single-taste-cell | 1 |
| 155 | whole-tumour-cell | 1 |
| 156 | 25-ml | 3 |
| 157 | exercise-albuterol | 2 |
| 158 | ha/dbm | 1 |
| 159 | random | 8,926 |
| 160 | sub-random | 1 |
| 161 | design-random | 2 |
| 162 | non-random | 74 |
| 163 | pseudo-random | 9 |
| 164 | concealed-to-random | 1 |
| 165 | nonrandom | 48 |
| 166 | pseudorandom | 9 |
| 167 | postrandom | 1 |
| 168 | study-arm | 1 |
| 169 | stable-calcium | 1 |
| 170 | bothriocephalidean | 1 |
| 171 | syndinian | 1 |
| 172 | salivarian | 1 |
| 173 | rhodophytan | 1 |
| 174 | low-nitrogen | 1 |
| 175 | odd/even | 1 |
| 176 | c-myc-driven | 1 |
| 177 | respondent-driven | 28 |
| 178 | monoxen | 1 |
| 179 | hypothermia-in | 1 |
| 180 | reported.in | 1 |
| 181 | society.in | 1 |
| 182 | sensor-off/on | 1 |
| 183 | random-allocation | 2 |
| 184 | randomisation-allocation | 1 |
| 185 | deprotonation/oxidation | 1 |
| 186 | cluster-randomization | 4 |
| 187 | wavenumber-linearization | 1 |
| 188 | reasoned/intention | 2 |
| 189 | nikon | 4 |
| 190 | methane-xenon | 1 |
| 191 | ch3cn-h2o | 1 |
| 192 | lipari-szabo | 1 |
| 193 | furosemide-placebo | 1 |
| 194 | 150-bp | 1 |
| 195 | 661bp | 1 |
| 196 | lichrosep | 1 |
| 197 | per-group | 1 |
| 198 | study-group | 17 |
| 199 | patient/group | 1 |
| 200 | thy-car | 1 |
| 201 | r-u5-5'leader | 2 |
| 202 | spliced-leader | 1 |
| 203 | free-rider | 1 |
| 204 | triplet/higher | 1 |
| 205 | multiplier | 14 |
| 206 | filtered-seawater | 2 |
| 207 | nanoliter | 1 |
| 208 | cover-to-cover | 1 |
| 209 | itsr | 1 |
| 210 | vol-tas | 1 |
| 211 | lac-ga-cs | 1 |
| 212 | caudovirales | 2 |
| 213 | mucorales | 2 |
| 214 | multiple-locus | 2 |
| 215 | multi-locus | 20 |
| 216 | multilocus | 68 |
| 217 | pfge/multilocus | 1 |
| 218 | möbius | 7 |
| 219 | discriminative-stimulus | 3 |
| 220 | tki-everolimus | 1 |
| 221 | poisonings.exact | 1 |
| 222 | hospitalet | 1 |
| 223 | figure-eight | 5 |
| 224 | four-digit | 3 |
| 225 | antiinflammatory/antioxidant | 1 |
| 226 | telomere-dependent | 1 |
| 227 | gh-independent | 1 |
| 228 | 283-patient | 1 |
| 229 | 5,518-patient | 2 |
| 230 | clinic/patient | 1 |
| 231 | 4-element | 1 |
| 232 | 5-element | 1 |
| 233 | data/measurement | 1 |
| 234 | blind-to-treatment | 1 |
| 235 | 1.5st | 1 |
| 236 | three-host | 1 |
| 237 | peak-first | 2 |
| 238 | pseudo-first | 7 |
| 239 | pap/watt | 1 |
| 240 | meaning/context | 1 |
| 241 | structurally-complex | 1 |
| 242 | tyr-lys-asp-gly | 1 |
| 243 | dative-only | 1 |
| 244 | saturation-recovery | 2 |
| 245 | alleatory | 1 |
| 246 | maize-poultry | 1 |
| 247 | 'country | 1 |
| 248 | spin-parity | 1 |
| 249 | high-cell-density | 1 |
| 250 | tenax-ta™ | 2 |